Latest

Early intervention in a mouse model of Dravet Syndrome prevented onset of critical disease symptoms.

Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?

Re-engineering immune cells helps reverse immune dysregulation associated with autoimmune diseases.